SCHEDULE 13G Filed 2026-06-10 Event — SEC 0001104659-26-072388 →

INTEGRATED CORE STRATEGIES (US) LLC → Quince Therapeutics, Inc. QNCX

Stake: — Shares: — Class: Common Stock, par value $0.001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 15/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Short interest building (+19.2% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

13 filings by this filer

12 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 2.67

59,944 shares short · +19.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $281K

Point72 Asset Mgmt

Other 13D/G Filings on Quince Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-10-14	SCHEDULE 13G	Foresite Capital Fund VI LP	—	—	view →
2026-10-14	SCHEDULE 13G	PERCEPTIVE ADVISORS LLC	—	—	view →

Other Filings by INTEGRATED CORE STRATEGIES (US) LLC

Filed	Form	Issuer	Stake	Shares
2026-10-23	SCHEDULE 13G/A	Beacon Financial Corporation	—	—	view →
2026-10-05	SCHEDULE 13G	First Horizon Corporation	—	—	view →
2026-09-22	SCHEDULE 13G	Better Home & Finance Holding Company	—	—	view →
2026-09-04	SCHEDULE 13G	Karyopharm Therapeutics Inc.	—	—	view →
2026-09-01	SCHEDULE 13G	Fortress Biotech, Inc.	—	—	view →
2026-08-24	SCHEDULE 13G	Collegium Pharmaceutical, Inc.	—	—	view →
2026-08-24	SCHEDULE 13G	Tenaya Therapeutics, Inc.	—	—	view →
2026-06-18	SCHEDULE 13G	Edesa Biotech, Inc. EDSA	—	—	view →
2026-06-17	SCHEDULE 13G	TPG Inc. TPGXL	—	—	view →
2026-06-11	SCHEDULE 13G	Once Upon a Farm, PBC OFRM	—	—	view →
2026-05-26	SCHEDULE 13G	Amanat Acquisition Corp AMAN	—	—	view →
2018-01-08	SC	TETRAPHASE PHARMACEUTICALS INC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →